Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Venous Thromboembolism 4Venous Thrombosis 2Pulmonary Embolism 2Neoplasms 2Thrombosis 1Embolism 1

Interventions

Dalteparin 10apixaban 5Tinzaparin 4Enoxaparin 4Heparin, Low-Molecular-Weight 3edoxaban 2bemiparin 2abelacimab 2Warfarin 2MAA868 2Fondaparinux 2Dabigatran 2reviparin 1isoquercitrin 1certoparin 1calcium heparin 1acarboxyprothrombin 1Rosuvastatin Calcium 1Rivaroxaban 1Phenprocoumon 1Nadroparin 1Heparin 1Educational Status 1Acenocoumarol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Venous Thrombosis × Dabigatran × Classical hematology × Clear all
NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT03240120 2019-04-17

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

The University of Hong Kong

Phase 3 Unknown
99 enrolled
Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡